Compare Fujifilm vs Lifetrack Medical Systems
Customers evaluate the quality of Fujifilm's products using the following success metrics.
Overview
Fujifilm is based in United States
Fujifilm manufactures, markets, and provides service for a broad spectrum of industries including photographic, medical imaging and informatics, pharmaceutical, regenerative medicine, and biopharmaceutical contract manufacturing. It is based in Valhalla, New York.
Lifetrack Medical Systems is 12 yrs old and is based in Singapore.
Lifetrack Medical Systems is a Singapore and Philippines-based health tech startup that develops and deploys a scalable, fully distributed medical imaging software designed for affordable access for the two-thirds of the world’s population that currently lack it. The software has been used across Asia, North America, Europe, and Africa to allow customers to scale and integrate their radiology operations.
Demo Video
Product
Information not available because Fujifilm has not claimed their profile.
Work for Fujifilm? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Fujifilm?
Claim your profile now.
Why Lifetrack Medical Systems beats Fujifilm
- Cost effective, deployment set up flexibility, fast deployment time
Benefits
- Case turnaround times
- Patient studies processed
Products
LifeSys
Hybrid, cloud, or on premise RIS/PACS solution that is zero footprint and can be remotely deployed.
Customers
Lifetrack Medical Systems works with 3 known companies.
Known Partners
FamilyDoc, MyHealth
Why They Buy
News & Analysis
Fujifilm has not been mentioned in our research.
Lifetrack Medical Systems has been mentioned in our research 1 time.
Research Articles
Expert Collections
Digital Health 150
150 items
The most promising digital health startups transforming the healthcare industry
Digital Health
10,567 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.